Benoit Thibault

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Morphometric analysis of neoplastic cell clusters in high-grade serous ovarian cancer ascites identifies a promising prognostic factor: a retrospective study.

Morphometric analysis of neoplastic cell clusters in high-grade serous ovarian cancer ascites identifies a promising prognostic factor: a retrospective study.

Journal: Journal of ovarian research

Published: November 27, 2024

PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells.

PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells.

Journal: Scientific reports

Published: November 13, 2024

Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells.

Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells.

Journal: Life science alliance

Published: May 30, 2024

Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.

Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.

Journal: Cancers

Published: December 02, 2022

Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent.

Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent.

Journal: The Biochemical journal

Published: January 04, 2021

Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance.

Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance.

Journal: Molecular cancer therapeutics

Published: November 23, 2020

Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component.

Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component.

Journal: EMBO molecular medicine

Published: September 23, 2020

Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.

Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.

Journal: Journal of molecular cell biology

Published: January 03, 2019

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.

Journal: Scientific reports

Published: August 01, 2018

Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.

Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.

Journal: Cancers

Published: May 09, 2018

Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance.

Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance.

Journal: Oncotarget

Published: November 27, 2017

Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.

Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.

Journal: Oncotarget

Published: July 27, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026